Showing results (81-90 of 435) with videos related to
Sort By:
Pageof 44
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple MyelomaMeletios-Athanasios Dimopoulos, Paul Richardson, Sagar LonialClinical Advances in Hematology & Oncology : H&O|March 19, 2021
Antibody treatment in multiple myelomaKathryn T Maples, Catherine Johnson, Sagar LonialExpert Opinion on Investigational Drugs|March 13, 2012
Panobinostat for the treatment of multiple myelomaPaola Neri, Nizar J Bahlis, Sagar LonialClinical Lymphoma & Myeloma|March 2, 2006
Novel treatment approaches for patients with multiple myelomaRajni Sinha, Jonathan L Kaufman, Sagar LonialBiomed Research International|December 19, 2013
From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseasesRaghavan Chinnadurai, Edmund K Waller, Jacques Galipeau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple MyelomaPaola Neri, Nizar J Bahlis, Sagar LonialCancer|November 6, 2018
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myelomaAjai Chari, Sagar Lonial, Tomer M Mark, et al.Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 InstitutesCindy Varga, Myra Robinson, Vikas Gupta, et al.Clinical Lymphoma & Myeloma|November 21, 2007
Maintenance therapy in lymphomaRonald Mihelic, Jonathan Kaufman, Sagar Lonial, et al.Pageof 44